Sanofi signs letter of intent with Tricog Health EP News Bureau Sep 8, 2026 Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup that…
Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with… EP News Bureau Jun 24, 2022 Ahammune’s investigational new drug for vitiligo- AB1001 has mechanism of action that targets pathways involved in triggering…
